Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 3/2000

01-03-2000 | ORIGINAL ARTICLE

A phase II study of Biotene in the treatment of postradiation xerostomia in patients with head and neck cancer

Authors: P. Warde, B. Kroll, B. O'Sullivan, J. Aslanidis, E. Tew-George, J. Waldron, W. Maxymiw, F.-F. Liu, D. Payne, B. Cummings

Published in: Supportive Care in Cancer | Issue 3/2000

Login to get access
Metadata
Title
A phase II study of Biotene in the treatment of postradiation xerostomia in patients with head and neck cancer
Authors
P. Warde
B. Kroll
B. O'Sullivan
J. Aslanidis
E. Tew-George
J. Waldron
W. Maxymiw
F.-F. Liu
D. Payne
B. Cummings
Publication date
01-03-2000
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 3/2000
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s005200050286

Other articles of this Issue 3/2000

Supportive Care in Cancer 3/2000 Go to the issue

ORIGINAL ARTICLE

Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction

ORIGINAL ARTICLE

A prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosis

ORIGINAL ARTICLE

Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale

OriginalPaper

SUPPORTIVE CARE NEWS

ORIGINAL ARTICLE

Low-dose continuous-infusion ceftazidime monotherapy in low-risk febrile neutropenic patients

REVIEW ARTICLE

Cachexia and anorexia: cancer's covert killer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits